O
CFN

OrbiMed’s CAREFUSION CORPORATION CFN Stock Holding History

OrbiMed’s Portfolio CFN Stock Details CFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,756,000
Closed -$215M – 144
2014
Q3 		$215M Buy
4,756,000
+1,085,000
+30% +$48.9M 2.25% 14
2014
Q2 		$163M Buy
3,671,000
+1,659,000
+82% +$68.7M 1.91% 20
2014
Q1 		$80.9M Sell
2,012,000
-159,500
-7% -$6.45M 1% 33
2013
Q4 		$86.5M Buy
2,171,500
+968,200
+80% +$37.6M 1.27% 27
2013
Q3 		$44.4M Buy
1,203,300
+1,048,400
+677% +$39.1M 0.79% 36
2013
Q2 		$5.71M Buy
+154,900
New +$5.48M 0.12% 98

Other funds holding CFN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed's CFN Position: Q4 2014 in Review

OrbiMed sold out of CAREFUSION CORPORATION (CFN) in Q4 2014, closing a stake of 4,756,000 shares — an estimated $215M sold.

OrbiMed first reported a position in CFN in Q2 2013 and held it in 6 quarters. The position peaked at $215M in Q3 2014. 449 funds tracked by Wall St. Rank hold CFN as of Q4 2014.

  • OrbiMed reported no remaining CAREFUSION CORPORATION position as of Q4 2014 after selling out during the quarter.
  • OrbiMed sold 4,756,000 CAREFUSION CORPORATION shares in Q4 2014, an estimated $215M.
  • OrbiMed first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 6 quarters.
  • OrbiMed's CAREFUSION CORPORATION position peaked at $215M in Q3 2014.
  • 449 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q4 2014.

Based on OrbiMed's 13F filing for Q4 2014, filed 13 Feb 2015.